DrCeSarcoma Profile Banner
César Serrano García Profile
César Serrano García

@DrCeSarcoma

Followers
3K
Following
13K
Media
391
Statuses
4K

Physician-scientist · #sarcoma #GIST @VHIO | External Group Leader @IRBBarcelona | #SanidadPública | #SinCienciaNoHayFuturo | @MyEsmo Faculty. Tweets are my own

Barcelona / de Salamanca
Joined June 2018
Don't wanna be here? Send us removal request.
@DrCeSarcoma
César Serrano García
2 years
🤩 Ha sido todo un honor recibir la beca CRIS de Excelencia dotada con 1.25M€ para diseccionar a un nivel sin precedentes los mecanismos moleculares de los #Sarcomas #GIST - y poder avanzar en el tratamiento de nuestros pacientes 🧬💊 🙏🏼 Muchas gracias a la #CRIScontraelcáncer
@criscancer
CRIS contra el cáncer
2 years
🔴 Para el Dr. @DrCeSarcoma del @VHIO de Barcelona por el Proyecto CRIS de Sarcomas Gastrointestinales.  ➡️ Entrega el Dr. Kevin Harrington, jefe del servicio de Radioterapia e Imagen del @CTI_ICR#CRIScontraelcáncer #OtraOportunidad #DíaCienciaCRIS24
44
30
218
@DraMartinezLago
Nieves Martinez Lago MD PhD
3 days
🧬 Secondary Genetic Alterations in Translocation-Associated Sarcomas 📊 SGAs detected: 51% (88% in myxoid liposarcoma) 🧪 Most frequent: TP53 (ES 11%, SFT 26%) ⚠️ Prognosis: SGAs → ↑ metastasis & worse PFS/DSS 💡 TERT promoter mutations also linked to poor outcomes 🔗
Tweet card summary image
ascopubs.org
PURPOSETranslocation-associated sarcomas (TASs) encompass a wide spectrum of pathologic entities and clinical behavior. Driven by the oncogenic fusion, TASs typically show a stable genome and a low...
0
5
10
@VHIO
Vall d’Hebron Institute of Oncology (VHIO)
3 days
🧬 Recientemente publicado en @JAMAOnc: un grupo internacional de expertos, liderado por @DrCeSarcoma (#VHIO), publica la primera guía de recomendaciones del uso de la secuenciación genómica en el manejo de pacientes con #sarcoma ➡️ https://t.co/hLFjyiJgnq
0
3
8
@GrupoGeis
GEIS
6 days
Abierta la 1ª convocatoria de la Beca ENARAK BEHAR ZAITU 28.000 € + 2.000 € para gastos indirectos, para proyectos de investigación en sarcomas retroperitoneales. 📅 Plazo: hasta el 15 de noviembre de 2025 📩 secretaria@grupogeis.org 👉 Más info: https://t.co/Y24VMCtF38
0
3
3
@VHIO
Vall d’Hebron Institute of Oncology (VHIO)
7 days
📣 New VHIO-@CaixaResearch Scientific Seminar‼️ 🔹 Transcriptional Dysregulation in Cancer 👩‍🔬  Dr. Ping Chi, @MSKCancerCenter & @WeillCornell  🗓 Friday, 31st October at 12h Hosted by: @DrCeSarcoma Register at 👉 scientific.seminars@vhio.net
0
2
5
@DraMartinezLago
Nieves Martinez Lago MD PhD
8 days
Long-term Nirogacestat in Desmoid Tumors — DeFi Trial 📊 Ph III, ≥4y follow-up ✅ ORR 45.7% (↑ CR + PR) ⏱️ mPFS not reached 📉 Ongoing tumor shrinkage + QoL benefits 💊 TEAEs ↓ incidence/severity ➡️ Nirogacestat maintains efficacy & tolerability 🔗 https://t.co/VyDdsMU77c
0
8
20
@eChinaHealth
eChinaHealth
9 days
9,606 Chinese physicians joined virtually for the “Dialogue on Bone and Soft-tissue Tumor Standard of Care” during ESMO 2025. A heartfelt thank you to all the speakers for making this event a success! @herbloong @CUHKMedicine @DrCeSarcoma @VHIO @seppobauer #bone #sarcoma
1
2
4
@VHIO
Vall d’Hebron Institute of Oncology (VHIO)
13 days
💬 Sara Cervelló, paciente y miembro @CMMetastasico, y @DrCeSarcoma, jefe de grupo #VHIO, te invitan a la Jornada de Participación de Pacientes en la Investigación Oncológica del VHIO.  🗓️ 5/11 ⏰ 9 h 📲 Inscríbete ➡️ https://t.co/mt337Um8Sq #SOMMVHIO https://t.co/K11sT8tF1o
0
3
4
@DrCeSarcoma
César Serrano García
13 days
‼️🆕 Just published in @JAMAOnc: Consensus guidelines for the use of #NGS in #sarcoma pts: 🤔Little data supporting routine, nonselective use 🔬💊Potential benefit in selected entities 🏥Sarcoma experts are critical 🧬BUT we need more molecular data! ▶️ https://t.co/FZoVvA5EMm
4
23
56
@schoffski
Patrick Schöffski
13 days
I wish all spider plots from sarcoma trials would look like the one from the recent update of the DeFi trial leading to regulatory approval of nirogacestat in US and Europe for our patients with desmoid fibromatosis. https://t.co/MFHuEfp4Cx
0
7
19
@Timothee_MD
Timothée Olivier, MD
17 days
#ESMO25 this couldn't be more timely ! "Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment" out in @JAMAOnc @DrCeSarcoma et al.! @jeanyvesblay See the very wise conclusion! + full paper here: https://t.co/4cwvaZRrXc
1
11
22
@DraMartinezLago
Nieves Martinez Lago MD PhD
20 days
📣 @GrupoGeis 2025 STS #Guidelines 🧬 Multidisciplinary mgmt in expert centers 🩻 MRI pre-biopsy; Core needle biopsy in referral units 💊 Surgery w/ clear margins key; RT/ChT select cases 🎯 Systemic tx: Doxo, Ifo, trabectedin, Gem , Eri, TT… 🔗 https://t.co/FtCSV5iEGO
0
5
10
@JoanMonte
Joan Montero
25 days
Great lab and outstanding PI!
@DrCeSarcoma
César Serrano García
27 days
🚨Open postdoc position at @VHIO - Barcelona! 🧑‍🔬Willing to pursue an academic career? 🧬Are you passionate about #DNArepair #ChromosomeInstability #TumorEvolution 💊Willing that your research impacts on patients? 💻 https://t.co/4ud5b46zdS Please apply 👉 https://t.co/2Z2xU0GvjM
0
2
1
@CrisMayorRuiz
Cris Mayor-Ruiz
26 days
Highly recommended!! 👇👇
@DrCeSarcoma
César Serrano García
27 days
🚨Open postdoc position at @VHIO - Barcelona! 🧑‍🔬Willing to pursue an academic career? 🧬Are you passionate about #DNArepair #ChromosomeInstability #TumorEvolution 💊Willing that your research impacts on patients? 💻 https://t.co/4ud5b46zdS Please apply 👉 https://t.co/2Z2xU0GvjM
0
2
2
@DrCeSarcoma
César Serrano García
27 days
🚨Open postdoc position at @VHIO - Barcelona! 🧑‍🔬Willing to pursue an academic career? 🧬Are you passionate about #DNArepair #ChromosomeInstability #TumorEvolution 💊Willing that your research impacts on patients? 💻 https://t.co/4ud5b46zdS Please apply 👉 https://t.co/2Z2xU0GvjM
0
10
11
@KonstantinosLin
Konstantinos LinosMD
28 days
Hot off the press! 📷 Our new article on PRRX1-rearranged fibroblastic tumors. https://t.co/3ZsH7pfAEC #pathology #BSTPath #oncology
2
16
40
@ElizSMcKenna
Elizabeth McKenna
1 month
Now online in @CD_AACR: Epigenetic and Transcriptional Programs Define #Osteosarcoma Subtypes and Establish Targetable Vulnerabilities - by Eunice López-Fuentes, @ASweetcordero, @SweetCorderoLab, and colleagues https://t.co/QqehgR8Yym @UCSF
1
9
15
@ElizSMcKenna
Elizabeth McKenna
1 month
Now online in @CD_AACR: Epigenetic Regulation of Chromosomal Instability by EZH2 Methyltransferase - by Yang Bai, @Samuel_Bakhoum, @mittallab, and colleagues https://t.co/no8n3BGJET @WeillCornell
0
20
67
@Greg_Charville
Greg Charville
1 month
Secondary genetic alterations can alter the morphology and behavior of fusion-driven sarcomas - this Ewing sarcoma exhibits variant biphasic morphology correlating with subclonal TP53 mutation (IHC is p53)
4
15
60
@GrupoGeis
GEIS
1 month
Quedan pocos días para la Sarcoma’s Week 📚Curso anual Sarcomas (1-2 Oct) 💪Workshop IMPERAS (1 Oct, 4ª Edición) 🔬2º Curso de Sarcomas de IMPERAS (2 Oct) ✍🏼Curso de Enfermería en Sarcomas (2 Oct) 🙌Simposio de Pacientes (2 Oct) 🌍XXIII GEIS International Symposium (3 Oct)
0
8
9